|
Home | Your Profile | Search | About Us | Pricing | Disclaimer |
|
|
|
 |
Home |  |
|
Outsourcing Reports | |
|
Outsourcing Showcase | |
 |
Reports Store |  |
|
Outsourcing Directory | |
|
Events | |
|
Advertising | |
|
News | |
| | Help |
1 Item, CDN $ 2650 |
Go Back  |
|||
Abstract Over the past 30 years the biotechnology industry has evolved rapidly, resulting in changes to biopartnering dynamics. Out-licensors now command greater power and leverage over the licensing of their technologies, changing the approach of out-licensing at various stages of the lifecycle and highlighting the need for biotechnology companies to adapt existing strategies to optimize this process. ‘Biopartnering Strategies’ is a unique report from the Drug Discovery series that provides an essential guide to the biopartnering process, for both in-licensing and out-licensing companies. Detailed case studies of biopartnering strategies at different phases of lifecycle development and in-depth analysis of deal trends will ensure that you can identify best practice alliance and licensing strategies and formulate successful deals. Use this report to implement the optimal biopartnering strategy for your company’s needs as it progresses through the ‘pioneer’, ‘growth’ and ‘consolidation’ stages of the lifecycle and ensure you recognize opportunities for growth in this high profit market. Key Questions answered by this report: • Why is biopartnering important in the biotechnology and pharmaceutical industries? • What are the recent trends in biopartnering activity? • What are the best practices in developing an effective biopartnering process? • How do biopartnering objectives differ across the various stages of the biotechnology lifecycle? • What are the key challenges associated with biopartnering at different evolutionary phases of development? • What lessons can be drawn from the successful biopartnering strategies of leading biotechnology companies? Top 5 reasons to purchase • Understand current and future biopartnering trends in order to formulate successful biotechnology licensing strategies. • Gain access to a survey of licensing experts ensuring you implement optimal licensing processes and commit adequate resources to support deal-making. • Profile the leading deals and deal-makers, identify key factors of success at various stages of lifecycle development and apply recommendations outlined in this report. Table of Contents Click here to view the Table of Contents | |||
Using the Site Privacy & Security Statement
Advertise with us Directory Guide
CanBiotech Newsletters
© 2000-2010 CanBiotech™ Inc.